Clinical Study
The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer
Table 2
Evaluations screening strategies, prevention measures, and pharmacological treatment of osteoporosis.
| Patient with BMD at baseline visit | 58.8% (87/148) | Patient with BMD at any followup visit | 20.3% (30/148) | Vitamin D supplementation during followup | 36.9% (55/149) | Calcium supplementation during followup | 35.6% (53/149) | Bisphosphonate use during followup | 12.7% (18/142) | Calcitonin use during followup | 0% (0/148) | Either a repeat BMD or treatment with a bisphosphonate during followup | 28.4% (42/148) |
|
|